This list is an analysis based on recent market events. It's not an investment recommendation.
About
Phase Holographic Imaging PHI AB (publ) develops and markets time-lapse cytometry instrumentation and software products in Europe, Asia, Australia, and North America. Its products include HoloMonitor M4, a live cell imaging microscope system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; and HoloMonitor, an app suite software that offers user interface with self-explanatory workflow from experiment setup to data presentation. The company also offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to avoid internal condensation of HoloMonitor. Its products are used in cell quality check, counting, proliferation, motility, migration, morphology, and tracking, as well as dose responses and wound healing. The company was incorporated in 1997 and is based in Lund, Sweden.
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Phase Holographic stocks are traded under the ticker PHI-BT-UN.ST.
In which sector is Phase Holographic located?▼
Phase Holographic operates in the Health & Wellness sector.
When did Phase Holographic complete a stock split?▼
Phase Holographic has not had any recent stock splits.
Where is Phase Holographic headquartered?▼
Phase Holographic is headquartered in Lund, Sweden.